miRNA Sequencing and Assay Market Gains Momentum in Oncology Applications

The global miRNA sequencing and assay market is poised for significant growth, with the market size expected to expand from USD 384.6 million in 2026 to USD 631.8 million by 2033. This expansion represents a compound annual growth rate (CAGR) of 5.8% during the forecast period from 2026 to 2033. The growing applications of miRNA sequencing in various sectors such as oncology, drug discovery, and clinical diagnostics, along with advancements in sequencing technologies, are driving the market's growth. This article delves into the current state of the market, its segmentation, trends, challenges, opportunities, and the key players shaping the industry.